Some medical workers and government employees in Moscow have been invited to receive what Russia says is the world’s first COVID-19 vaccine, which has been deemed to be safe after passing clinical trials, according to a report.
At least one hospital is preparing lists of workers who want to be inoculated with the drug developed by Moscow-based Gamaleya Institute, a doctor who received an invitation told Bloomberg News.
A city government official said that similar invitations for volunteers to receive the vaccination had been sent out to staffers, according to Bloomberg, which reported that it had seen one of the letters.
The Moscow City Government’s press service declined to comment to the outlet.
The Gamaleya vaccine, which was developed with the Russian Direct Investment Fund, is expected to received conditional registration this month, requiring trials on 1,600 more people, Bloomberg reported.
Production is expected to begin in September, Deputy Prime Minister Tatyana Golikova told President Vladimir Putin during a July 29 meeting.
Regulators plan to register the vaccine by Wednesday, a person familiar with the process told Bloomberg.
The testing data on the vaccine hasn’t been published yet, however, and the speed with which Russia is moving to make the inoculation available has raised questions in other countries, the outlet noted.
Share this article:
Source: Read Full Article